...
首页> 外文期刊>European review for medical and pharmacological sciences. >Expression of lncRNA TUG1 in hypertensive patients and its relationship with change state of an illness
【24h】

Expression of lncRNA TUG1 in hypertensive patients and its relationship with change state of an illness

机译:LNCRNA Tug1在高血压患者中的表达及其与疾病变革状态的关系

获取原文
   

获取外文期刊封面封底 >>

       

摘要

OBJECTIVE: To investigate the expression of LncRNA TUG1 in hypertensive patients and its relationship with the change state of illness. PATIENTS AND METHODS: A prospective analysis was carried out. Eighty-two patients with hypertension admitted to our hospital from March 2016 to February 2019 were regarded as a research group, and 79 healthy people admitted to our hospital during the same period were regarded as a control group. The serum LncRNA TUG1, platelet activating factor (PAF), endothelin-1 (ET-1), serum tumor necrosis factor-α (TNF-α), high sensitive C-reactive protein (hsCRP), and the relationship between the expression of LncRNA TUG1 and the clinicopathological characteristics of patients with hypertension in the two groups were detected, and finally, the risk factors of hypertension were analyzed. RESULTS: The expression levels of LncRNA TUG1, PAF, ET-1, TNF-α, and hsCRP in the serum of patients in research group were significantly higher than those in control group (p0.05). LncRNA TUG1 has a positive correlation with the severity of an illness of hypertensive patients (r=0.881, p0.001), and also has a positive correlation with the expression levels of PAF, ET-1, TNF-α, and hsCRP (r=0.735, p0.001; r=0.756, p0.001; r=0.712, p0.05; r=0.723, p0.05). The expression of LncRNA TUG1 in the serum of patients with hypertension was related to hypertension mode, severity of disease, hyperlipidemia, and obesity (p0.05). Obesity (OR: 3.469, 95% CI: 2.175-4.095), drinking (OR: 3.677, 95% CI: 1.695-4.892), hyperlipidemia (OR: 3.374, 95% CI: 1.759-6.988), and the high expression of TUG1 (OR: 2.693, 95% CI: 1.679-7.472) are independent risk factors for the attack of hypertension. CONCLUSIONS: LncRNA TUG1 is highly expressed in the serum of hypertensive patients and it is closely related to the progression of hypertension. Also, it may be one of the independent risk factors for hypertension and a new molecular target for hypertension treatment.
机译:目的:探讨LNCRNA Tug1在高血压患者中的表达及其与疾病变化状态的关系。患者及方法:进行了前瞻性分析。 2016年3月至2019年3月入院的八十二名高血压患者被视为2019年2月,被视为一个研究小组,在同一时期内录取的79名健康人士被视为一个对照组。血清LNCRNA Tug1,血小板活化因子(PAF),内皮素-1(ET-1),血清肿瘤坏死因子-α(TNF-α),高敏感的C-反应蛋白(HSCRP)和表达之间的关系检测到两组高血压患者的LNCRNA Tug1和临床病理特征,最后,分析了高血压的危险因素。结果:研究组患者血清LNCRNA Tug1,PAF,ET-1,TNF-α和HSCRP的表达水平明显高于对照组(P <0.05)。 Lncrana Tug1与高血压患者疾病的严重程度(r = 0.881,p <0.001)具有正相关性,并且还与PAF,ET-1,TNF-α和HSCRP的表达水平的正相关(R. = 0.735,p <0.001; r = 0.756,p <0.001; r = 0.712,p <0.05; r = 0.723,p <0.05)。高血压患者血清中LNCRNA Tug1的表达与高血压模式,疾病严重程度,高脂血症和肥胖(P <0.05)。肥胖(或:3.469,95%CI:2.175-4.095),饮酒(或3.677,95%CI:1.695-4.892),高脂血症(或:3.374,95%CI:1.759-6.988)和高表达Tug1(或:2.693,95%CI:1.679-7.472)是高血压袭击的独立风险因素。结论:LNCRNA Tug1在高血压患者血清中高度表达,与高血压进展密切相关。此外,它可能是高血压的独立危险因素之一,以及高血压治疗的新分子靶标的一种。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号